These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1544745)

  • 1. Sociodemographic factors and the declining prevalence of anti-hepatitis A antibodies in young adults in Israel: implications for the new hepatitis A vaccines.
    Green MS; Tsur S; Slepon R
    Int J Epidemiol; 1992 Feb; 21(1):136-41. PubMed ID: 1544745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A antibody prevalence among young adults in Israel--the decline continues.
    Gdalevich M; Grotto I; Mandel Y; Mimouni D; Shemer J; Ashkenazi I
    Epidemiol Infect; 1998 Oct; 121(2):477-9. PubMed ID: 9825802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibship size as a risk factor for hepatitis A infection.
    Green MS; Zaaide Y
    Am J Epidemiol; 1989 Apr; 129(4):800-5. PubMed ID: 2923125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in hepatitis A antibody prevalence among young adults in Israel.
    Kark JD; Camhy NA; Shany SB
    Public Health Rev; 1992-1993; 20(1-2):31-40. PubMed ID: 1305975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.
    Moschen ME; Floreani A; Zamparo E; Baldo V; Majori S; Gasparini V; Trivello R
    Eur J Epidemiol; 1997 Dec; 13(8):875-8. PubMed ID: 9476815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies against hepatitis A virus among new immigrants in Israel.
    Karetnyi YV; Mendelson E; Shlyakhov E; Rubinstein E; Golubev N; Levin R; Sandler M; Schreiber M; Rubinstein U; Shif I
    J Med Virol; 1995 May; 46(1):61-5. PubMed ID: 7623008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine testing for IgG antibodies against hepatitis A virus in Israel.
    Samuels N
    BMC Public Health; 2005 Jun; 5():60. PubMed ID: 15935104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
    Joshi N; Yr NK; Kumar A
    Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
    Wong KH; Liu YM; Ng PS; Young BW; Lee SS
    J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions.
    Zuin M; Caserta C; Romanò L; Mele A; Zanetti A; Cannatelli R; Giorgini A; Tagliacarne C; Amante A; Marcucci F; Battezzati PM
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):479-485. PubMed ID: 27785638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The declining pattern of seroepidemiology of hepatitis A virus infection among adolescents in Bangkok, Thailand.
    Poovorawan Y; Vimolkej T; Chongsrisawat V; Theamboonlers A; Chumdermpadetsuk S
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):154-7. PubMed ID: 9322299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prevention of hepatitis A in travelers.
    Steffen R; Kane MA; Shapiro CN; Billo N; Schoellhorn KJ; van Damme P
    JAMA; 1994 Sep; 272(11):885-9. PubMed ID: 8078167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic markers for hepatitis B virus and hepatitis A virus in Bushmen in West Caprivi, Namibia.
    Steele AD; Bos P; Joubert JJ; Bafort JM; Lecatsas G; Aspinall S
    East Afr Med J; 1995 Jan; 72(1):30-2. PubMed ID: 7781552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hepatitis A in Mediterranean countries.
    Papaevangelou G
    Vaccine; 1992; 10 Suppl 1():S63-6. PubMed ID: 1335662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of anti-HAV antibodies in selected groups of children].
    Ryszkowska A; Gładysz A; Inglot M; Molin I
    Przegl Epidemiol; 2000; 54(3-4):375-83. PubMed ID: 11349601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seroepidemiologic study of the prevalence of anti-HAV antibodies in children in Rome].
    Catania S; Ajassa C; Tzantzoglou S; Bellagamba R; Berardelli G; Catania N
    Riv Eur Sci Med Farmacol; 1996; 18(1):7-9. PubMed ID: 8766776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A virus seropositivity among hospital and community healthcare workers in Israel-the role of occupation, demography and socioeconomic background.
    Chodick G; Ashkenazi S; Aloni H; Peled T; Lerman Y
    J Hosp Infect; 2003 Jun; 54(2):135-40. PubMed ID: 12818588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing epidemiology of hepatitis A virus (HAV) infection: a comparative seroepidemiological study (1979 vs 1989) in north-east Italy.
    Chiaramonte M; Moschen ME; Stroffolini T; Rapicetta M; Bertin T; Renzulli G; Ngatchu T; Chionne P; Trivello R; Naccarato R
    Ital J Gastroenterol; 1991; 23(6):344-6. PubMed ID: 1742523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Hepatitis A virus (HAV) and Hepatitis E virus (HEV) in the patients presenting with acute viral hepatitis.
    Joon A; Rao P; Shenoy SM; Baliga S
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():102-5. PubMed ID: 25657123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective detection of a subclinical hepatitis A virus (HAV) epidemic affecting juvenile cohorts of the Hungarian population.
    Pohl O; Brojnás J; Rusvai E; Ordög K; Siska I; Faludi G; Kapusinszky B; Csohán A; Lendvai K; Lengyel A; Mezey I; Berencsi G
    FEMS Immunol Med Microbiol; 2003 Aug; 38(1):85-91. PubMed ID: 12900060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.